¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-16

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-16
±³À°ÀÏÀÚ : 2022-06-16
±³À°Àå¼Ò : ¿Â¶óÀÎ ¿¬¼ö±³À°(½Ç½Ã°£ È­»ó °­ÀÇ) ¹× ¼­¿ï·Ôµ¥È£ÅÚ 2, 3Ãþ 5°³·ë  
±³À°ÁÖÁ¦ : (¿Â∙¿ÀÇÁ¶óÀÎ º´Çà) Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѾÏÇÐȸ
´ã´çÀÚ : ÀÌÈñ¿¬
¿¬¶ôó : 02-792-1486  
À̸ÞÀÏ : cancer2@kams.or.kr      
±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¼Ò¾Æû¼Ò³â°ú, »êºÎÀΰú, Á¤Çü¿Ü°ú, ½Å°æ¿Ü°ú, ÈäºÎ¿Ü°ú, ¼ºÇü¿Ü°ú, ¾È°ú, À̺ñÀÎÈÄ°ú, ÇǺΰú, ºñ´¢ÀÇÇаú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, ¸¶ÃëÅëÁõÀÇÇаú, ½Å°æ°ú, Áø´Ü°Ë»çÀÇÇаú, º´¸®°ú, °¡Á¤ÀÇÇаú, ÇÙÀÇÇаú, ÀÀ±ÞÀÇÇаú¿¹¹æÀÇÇÐ, ÇغÎÇÐ, »ý¸®ÇÐ, »ýÈ­ÇÐ, ºÐÀÚ»ý¹°ÇÐ, ¹Ì»ý¹°ÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 22 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 200,000¿ø      
ºñ°í 1. ȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 10¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 10¸¸¿ø2. ºñȸ¿ø: 1) ±³¼ö, Àü¹®ÀÇ, ¼±ÀÓ¿¬±¸¿ø: 15¸¸¿ø / 2) Àü°øÀÇ, ¿¬±¸¿ø, ´ëÇпø»ý: 5¸¸¿ø / 3) ¾÷ü ¹× ¿¬±¸¼Ò: 20¸¸¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-16 Room A 08:40~09:05 Human carcinogens in Asia  Ian A Cree(World Health Organization, France) 
±³À°½Ã°£ 06-16 Room A 09:05~09:30 Diet and cancer risk in Asia  ÀÌÁ¤Àº(¼­¿ï´ë »ý°ú´ë) 
±³À°½Ã°£ 06-16 Room A 09:30~09:55 Modifiable and unmodifiable risk factors for cancer in Asia  Manami Inoue(National Cancer Center, Japan) 
±³À°½Ã°£ 06-16 Room A 09:55~10:20 Current Status and prevention of Occupational carcinogen exposure in Asia  ±èÀξÆ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 06-16 Room B 08:40~09:05 Cryo-EM study of transmembrane protein and antibody complexes  ÀÌÁö¿À(POSTECH) 
±³À°½Ã°£ 06-16 Room B 09:05~09:30 Proteomics and application in translational research  ±è°æ°ï(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-16 Room B 09:30~09:55 Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer  Adriana Franco Paes Leme(Brazilian Biosciences National Laboratory (LNBio), Brazil) 
±³À°½Ã°£ 06-16 Room B 09:55~10:20 Machine learning powered next-generation proteomics  Lennart Martens(Ghent University, Belgium) 
±³À°½Ã°£ 06-16 Room D 08:40~09:05 Network-based machine-learning to predict drug efficacy in cancer patients  ±è»ó¿í(POSTECH) 
±³À°½Ã°£ 06-16 Room D 09:05~09:30 Applications of machine learning in cancer immunotherapy  ÃÖÁ¤±Õ(KAIST) 
±³À°½Ã°£ 06-16 Room D 09:30~09:55 AI on spatial tranome guides pathological decision making in cancer  ÀÌÁÖ»ó(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-16 Room D 09:55~10:20 Exploring phenotype patterns of breast cancer within somatic mutations  Hiroshi Mamitsuka(Kyoto University, Japan) 
±³À°½Ã°£ 06-16 Room E 08:40~09:05 Diagnosis of hereditary breast-ovarian cancer syndrome  ±èÁ¾¿ø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-16 Room E 09:05~09:30 Cancer screening recommendations for individuals with Li-Fraumeni syndrome  Mandy Ballinger(Garvan Institute of Medical Research, Australia) 
±³À°½Ã°£ 06-16 Room E 09:30~09:55 Screening and management of individuals with neurofibromatosis 1  ±èÇý¸®(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-16 Room E 09:55~10:20 Molecular characteristics, screening, and treatment of hereditary breast and ovarian cancer  Reiko Yoshida(Showa University, Japan) 
È޽Ġ06-16  10:20~10:40 È޽Ġ () 
±³À°½Ã°£ 06-16 Room A 10:40~11:20 Dynamic changes of tumor infiltrating immune cells during immunotherapies  Zemin Zhang(Peking University, China) 
±³À°½Ã°£ 06-16 Room A 11:20~12:00 The barriers in clinical application of cancer precision medicine: Lessons K-MASTER project  ±è¿­È«(°í·ÁÀÇ´ë) 
½Ä»ç 06-16  12:00~12:30 ½Ä»ç  () 
±³À°½Ã°£ 06-16 Room A 12:30~13:10 A new approval of novel combination, pembrolizumab plus lenvatinib in advanced RCC with CLEAR (KN581) data  ±èÀÎÈ£(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-16 Room D 12:30~13:10 Sotorasib, the first target therapy for kras g12c mt. NSCLC  ¹ÌÁ¤() 
È޽Ġ06-16  13:10~13:25 È޽Ġ () 
±³À°½Ã°£ 06-16 Room A 13:25~13:50 Molecular carcinogenesis of cholangiocarcinoma  Teh Bin Tean(National Cancer Center Singapore, Singapore) 
±³À°½Ã°£ 06-16 Room A 13:50~14:15 Liver transplantation for HCC  À̱¤¿õ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-16 Room A 14:15~14:40 Radiotherapy  Angela Gilselvania(Cipto Mangunkusumo National General Hospital, Indonesia) 
±³À°½Ã°£ 06-16 Room A 14:40~15:05 Emerging therapeutic options for HCC and cholangiocarcinoma  ±èÅ¿ë(¼­¿ï´ëº´¿ø) 
±³À°½Ã°£ 06-16 Room B 13:25~13:50 To be announced  Ross Soo(National University Cancer Institute, Singapore) 
±³À°½Ã°£ 06-16 Room B 13:50~14:15 Modulation of tumor immune responses by dead cell-derived molecules  Hideyuki Yanai(University of Tokyo, Japan) 
±³À°½Ã°£ 06-16 Room B 14:15~14:40 Towards next generation T cell engineering for cancer immunotherapy  ±èÂùÇõ(KAIST) 
±³À°½Ã°£ 06-16 Room B 14:40~15:05 To be announced  ÀÓ¼¼Áø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-16 Room D 13:25~13:50 Integrating digital pathology into clinical practice  Á¤Âù±Ç(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-16 Room D 13:50~14:15 Digitized network for pathologic diagnosis in Japan  Junya Fukuoka(Nagasaki University Graduate School of Biomedical Sciences, Japan) 
±³À°½Ã°£ 06-16 Room D 14:15~14:40 Digital pathology project in Korea  Àå±âÅÃ(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-16 Room D 14:40~15:05 Application of deep learning for cancer histological grading  Mattias Rantalainen(Karolinska Institutet, Sweden) 
±³À°½Ã°£ 06-16 Room E 13:25~13:55 Review of ctDNA analysis in patients with cancer  Jason D. Merker(University of North Carolina School of Medicine, USA) 
±³À°½Ã°£ 06-16 Room E 13:55~14:25 Monitoring minimal residual disease based on ctDNA in breast cancer  ÇÑ¿ø½Ä(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-16 Room E 14:25~14:55 Liquid biopsy for advanced NSCLC - IASLC consensus statement  Daniel Tan Shao Weng(National Cancer Center Singapore, Singapore) 
Åä·Ð 06-16 Room E 14:55~15:05 Q&A Discussion  () 
È޽Ġ06-16  15:05~15:25 È޽Ġ () 
±³À°½Ã°£ 06-16 Room A 15:25~15:45 Epidemiology of gastric cancer in Asia  Manami Inoue(National Cancer Center, Japan) 
±³À°½Ã°£ 06-16 Room A 15:45~16:05 Surgical oncology in Japan  Yasuhiro Kodera(Nagoya University, Japan) 
±³À°½Ã°£ 06-16 Room A 16:05~16:25 Surgical oncology in China  Jiafu Ji(Beijing Cancer Hospital, China) 
±³À°½Ã°£ 06-16 Room A 16:25~16:45 Medical oncology in the East  ¿Àµµ¿¬(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-16 Room A 16:45~17:05 Medical oncology in the West  Yelena Janjigian(Memorial Sloan Kettering Cancer Center, USA) 
±³À°½Ã°£ 06-16 Room B 15:25~15:50 Efficacy of 3-dimensional printed breast surgical guide in breast conserving surgery  °í¹ü¼®(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 06-16 Room B 15:50~16:15 Cutting edge technology of intraoperative near-infrared fluorescence Image during thoracic tumor surgery  ±èÇö±¸(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-16 Room B 16:15~16:40 Application of fluorescence imaging to liver cancer surgery  Xiaoying Wang(Liver Cancer Institute, Zhongshan Hospital, Fudan University, China) 
±³À°½Ã°£ 06-16 Room B 16:40~17:05 Utility of intraoperative fluorescence imaging in gynecologic cancer surgery  Mikel Gorostidi Pulgar(Donostia Hospital, Spain) 
±³À°½Ã°£ 06-16 Room D 15:25~15:50 Application of artificial intelligence in radiation oncology  Steve B. Jiang(University of Texas Southwestern Medical Center, USA) 
±³À°½Ã°£ 06-16 Room D 15:50~16:15 Autosegmentation of target volume and normal organ delineation  Norman Zhu(Manteia Medical Technologies Co., China) 
±³À°½Ã°£ 06-16 Room D 16:15~16:40 Ultra-high dose rate (FLASH) radiotherapy  Hiromitsu Iwata(Nagoya Proton Therapy Center, Japan) 
±³À°½Ã°£ 06-16 Room D 16:40~17:05 Proton minibeam technique for clinical application  ÀÓ¿µ°æ(±¹¸³¾Ï¼¾ÅÍ) 
±³À°½Ã°£ 06-16 Room E 15:25~15:50 MRD in hematologic oncology  Anthony S. Stein(City of Hope, USA) 
±³À°½Ã°£ 06-16 Room E 15:50~16:15 The role of Flow-, PCR- and NGS-based MRD in hematologic malignancies  ±è¸í½Å(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-16 Room E 16:15~16:40 Analysis of cfDNA in colon cancer  Claus Lindbjerg Andersen(Aarhus University Hospital, Denmark) 
±³À°½Ã°£ 06-16 Room E 16:40~17:05 Liquid Bx for MRD of breast cancer  ÀÌÇѺ°(¼­¿ï´ëº´¿ø) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-16""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦48Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ ¹× Á¦2ȸ ¾Æ½Ã¾ÆÁ¾¾çÇÐȸ ±¹Á¦Çмú´ëȸ : 2022-06-17
´ÙÀ½±Û (¿Â¶óÀÎ) 157ȸ ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø ¼ÒÈ­±â¼¾ÅÍ ¿¬¼ö±³À° : 2022-06-15
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 3 10:03:07
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 6 10:01:58
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 7 10:00:36
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 5 09:59:23
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 8 09:57:34
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 4 09:56:15
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 1 09:55:06
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 4 09:53:53
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 3 09:52:12
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 5 09:50:43
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 3 09:48:48
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 3 09:47:05
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 3 09:45:43
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 6 09:42:47
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 3 09:40:48
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷